Fishman Jay A LTD Merck & Co., Inc. Transaction History

Fishman Jay A LTD

$1.01 Billion
Q3 2024

A detailed history of Fishman Jay A LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Fishman Jay A LTD holds 158,971 shares of MRK stock, worth $15.8 Million. This represents 1.79% of its overall portfolio holdings.

Number of Shares

158,971

Previous 145,911 8.95%

Holding current value

$15.8 Million

Previous $18.1 Million 0.06%

% of portfolio

1.79%

Previous 1.9%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$111.15 - $128.97 $1.45 Million - $1.68 Million	13,060 Added 8.95%	158,971 $18.1 Million
Q2 2024 Aug 05, 2024	BUY	$123.8 - $132.96 $16.8 Million - $18.1 Million	136,011 Added 1373.85%	145,911 $18.1 Million
Q2 2024 Jul 31, 2024	SELL	$123.8 - $132.96 $15.5 Million - $16.7 Million	-125,416 Reduced 92.68%	9,900 $1.23 Million
Q1 2024 Apr 23, 2024	BUY	$113.24 - $131.95 $613,194 - $714,509	5,415 Added 4.17%	135,316 $17.9 Million
Q4 2023 Jan 24, 2024	BUY	$100.18 - $109.02 $13 Million - $14.2 Million	129,901 New	129,901 $14.2 Million
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $3.1 Million - $3.45 Million	30,150 Added 31.81%	124,936 $12.9 Million
Q2 2023 Aug 15, 2023	BUY	$108.61 - $118.38 $4.69 Million - $5.11 Million	43,175 Added 83.65%	94,786 $10.9 Million
Q1 2023 May 09, 2023	BUY	$102.94 - $114.86 $36,029 - $40,201	350 Added 0.68%	51,611 $5.49 Million
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $174,880 - $224,220	-2,000 Reduced 3.76%	51,261 $5.69 Million
Q3 2022 Oct 26, 2022	SELL	$84.53 - $94.96 $4,226 - $4,748	-50 Reduced 0.09%	53,261 $4.59 Million
Q2 2022 Aug 09, 2022	SELL	$83.49 - $94.64 $31,308 - $35,490	-375 Reduced 0.7%	53,311 $4.86 Million
Q1 2022 May 10, 2022	SELL	$73.51 - $82.4 $66,159 - $74,160	-900 Reduced 1.65%	53,686 $4.4 Million
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $174,845 - $219,016	-2,419 Reduced 4.24%	54,586 $4.18 Million
Q3 2021 Nov 08, 2021	SELL	$71.68 - $78.83 $335,104 - $368,530	-4,675 Reduced 7.58%	57,005 $4.28 Million
Q2 2021 Aug 09, 2021	SELL	$70.31 - $77.77 $264,365 - $292,415	-3,760 Reduced 5.75%	61,680 $4.8 Million
Q1 2021 May 03, 2021	SELL	$68.86 - $81.11 $272,134 - $320,546	-3,952 Reduced 5.7%	65,440 $4.81 Million
Q4 2020 Feb 10, 2021	SELL	$71.77 - $79.65 $350,596 - $389,090	-4,885 Reduced 6.58%	69,392 $5.42 Million
Q3 2020 Nov 10, 2020	BUY	$73.18 - $82.95 $447,276 - $506,990	6,112 Added 8.97%	74,277 $5.88 Million
Q2 2020 Aug 10, 2020	BUY	$70.42 - $80.13 $140,840 - $160,260	2,000 Added 3.02%	68,165 $5.03 Million
Q1 2020 May 13, 2020	BUY	$63.36 - $87.82 $611,740 - $847,902	9,655 Added 17.09%	66,165 $4.86 Million
Q1 2020 May 12, 2020	BUY	$63.36 - $87.82 $7,603 - $10,538	120 Added 0.21%	56,510 $4.15 Million
Q4 2019 Feb 04, 2020	BUY	$77.58 - $87.54 $2,327 - $2,626	30 Added 0.05%	56,390 $4.89 Million
Q3 2019 Nov 05, 2019	BUY	$76.08 - $82.93 $11,412 - $12,439	150 Added 0.27%	56,360 $4.53 Million
Q2 2019 Aug 06, 2019	SELL	$69.84 - $81.59 $20,952 - $24,477	-300 Reduced 0.53%	56,210 $0
Q1 2019 May 01, 2019	BUY	$69.58 - $79.36 $10,437 - $11,904	150 Added 0.27%	56,510 $0
Q4 2018 Feb 05, 2019	BUY	$65.24 - $75.71 $65,239 - $75,710	1,000 Added 1.81%	56,360 $4.11 Million
Q3 2018 Oct 31, 2018	SELL	$57.69 - $67.84 $34,614 - $40,704	-600 Reduced 1.07%	55,360 $0
Q1 2018 May 08, 2018	SELL	$50.96 - $59.23 $95,957 - $111,530	-1,883 Reduced 3.26%	55,960 $0
Q4 2017 Feb 05, 2018	SELL	$51.62 - $61.64 $511,554 - $610,852	-9,910 Reduced 14.63%	57,843 $0
Q3 2017 Oct 31, 2017	BUY	$58.67 - $63.13 $3.98 Million - $4.28 Million	67,753	67,753 $0

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fishman Jay A LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fishman Jay A LTD with notifications on news.

Account